MBK Partners has acquired a 99.5 percent stake in Medit, a Seoul-based 3D dental scanner and solutions provider, from its largest shareholder, Unison Capital for 2.4 trillion won.
The acquisition took place a month after MBK was selected as the preferred bidder over the world's renowned private equity and investment firms, such as Carlyle, KKR, and Blackstone.
Medit founder Jang Min-ho and the firm's specially related parties also agreed to reinvest a considerable amount of revenue into the company. They will remain as joint investors with MBK. The deal is expected to close sometime around the first quarter of 2023.
The acquisition took place amid projections of the dental scanner market here and abroad growing 30 percent each year until 2027.
Medit is a global leader in the market for dental scanner solutions. The company secured a market share of 22 percent in 2020, and the portion rose to 24 percent this year.
The Korean firm started expanding its global footing in the industry from 2018 and has so far established branches in major countries such as the United States, Germany and China. The company runs 230 dealerships in around 100 countries across the globe.
Medit generated sales of 190.5 billion won last year, but this year's sales are estimated to have soared to around 270 billion won.
The dental scanner industry was an oligopoly market, with a group of top five companies accounting for more than 85 percent of the total market share. But the investment banking industry forecasts Medit and 3Shape to continue to expand their dominance in the industry and intensify a two-way rivalry.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Approves Mitapivat for Anemia in Thalassemia Patients
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Washington Post Publisher Will Lewis Steps Down After Layoffs
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



